Anthera Pharmaceuticals Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Sales 2016 | 0.14 12.05 | Sales 2017 | - | Capitalization | 2.29Cr 189.95Cr |
---|---|---|---|---|---|
Net income 2016 | -5.5Cr -457.17Cr | Net income 2017 | -2.6Cr -216.12Cr | EV / Sales 2016 | 4,40,69,434 x |
Net cash position 2016 | 2.08Cr 173.25Cr | Net cash position 2017 | 21.96L 18Cr | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-0.29% | 2.18TCr | |
-9.28% | 1.81TCr | |
-41.70% | 1.67TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |